Developmental regulation and PKC dependence of Alzheimer's-type tau phosphorylations in cultured fetal rat hippocampal neurons

Developmental Brain Research

Volumn 107, Issue 1, 1998, Pages 143-158

  Combs, Colin K ^a   Coleman, Paul D ^a   O'Banion, M Kerry ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Alzheimer's disease; Microtubule associated proteins; Neuronal culture; PHF 1; Phosphorylation; Tau 1

Indexed keywords

PROTEIN KINASE C; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; HIPPOCAMPUS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; NEUROFIBRILLARY TANGLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REGULATORY MECHANISM; SOLUBILIZATION;

ALZHEIMER DISEASE; ANIMALS; ANTIBODIES, MONOCLONAL; CELL DIFFERENTIATION; CELLS, CULTURED; EMBRYONIC AND FETAL DEVELOPMENT; EPITOPES; FETUS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; NEURONS; PHOSPHORYLATION; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; TAU PROTEINS;

ANIMALIA; HIPPOCAMPUS HIPPOCAMPUS;

EID: 0032540311     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-3806(98)00019-4     Document Type: Article

References (120)

1. Adams P.D., Parker P.J. TPA-induced activation of MAP kinase. FEBS Lett. 290:1991;77-82.
2. Arendt T., Bruckner M.K. Perisomatic sprouts immunoreactive for nerve growth factor receptor and neurofibrillary degeneration affect different neuronal populations in the basal nucleus in patients with Alzheimer's disease. Neurosci. Lett. 148:1992;63-66.
3. Baas P.W., Black M.M., Banker G.A. Changes in microtubule polarity orientation during the development of hippocampal neurons in culture. J. Cell Biol. 109:1989;3085-3094.
4. Baas P.W., Pienkowski T.P., Kosik K.S. Processes induced by tau expression in sf9 cells have an axon-like microtubule organization. J. Cell Biol. 115:1991;1333-1344.
5. Banker G.A., Cowan M. Rat hippocampal neurons in dispersed cell culture. Brain Res. 126:1977;397-425.
6. Bartlett W.P., Banker G.A. An electron microscopic study of the development of axons and dendrites by hippocampal neurons in culture: I. Cells which develop without intercellular contacts. J. Neurosci. 4:1984;1944-1953.
7. Bartlett W.P., Banker G.A. An electron microscopic study of the development of axons and dendrites by hippocampal neurons in culture: II. Synaptic relationships. J. Neurosci. 4:1984;1954-1965.
8. Biernat J., Gustke N., Drewes G., Mandelkow E.M., Mandelkow E. Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding. Neuron. 11:1993;153-163.
9. Binder L.I., Frankfurter A., Rebhun L.I. The distribution of tau in the mammalian central nervous system. J. Cell Biol. 101:1985;1371-1378.
10. Brady R.M., Zinkowski R.P., Binder L.I. Presence of tau in isolated nuclei from human brain. Neurobiol. Aging. 16:1995;479-486.
11. Bramblett G.T., Goedert M., Jakes R., Merrick S.E., Trojanowski J.Q., Lee V.M. Abnormal tau phosphorylation at ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron. 10:1993;1089-1099.
12. Bramblett G.T., Trojanowski J.Q., Lee V.M. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins). Lab. Invest. 66:1992;212-222.
13. Brandt R., Lee G. Functional organization of microtubule-associated protein tau: identification of regions which affect microtubule growth, nucleation, and bundle formation in vitro. J. Biol. Chem. 268:1993;3414-3419.
14. Brion J.-P., Smith C., Couck A.-M., Gallo J.-M., Anderton B.H. Developmental changes in tau phosphorylation: fetal tau is transiently phosphorylated in a manner similar to paired helical filament-tau characteristic of Alzheimer's disease. J. Neurochem. 61:1993;2071-2080.
15. Busciglio J., Lorenzo A., Yeh J., Yankner B.A. Beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron. 14:1995;879-888.
16. Butner K.A., Kirschner M.W. Tau protein binds to microtubules through a flexible array of distributed weak sites. J. Cell Biol. 115:1991;717-730.
17. Butt E., Bemmelen M.v., Fischer L., Walter U., Jastorff B. Inhibition of cGMP-dependent protein kinase by (Rp)-guanosine 3′,5′-monophosphorothioates. FEBS Lett. 263:1990;47-50.
18. Caceres A., Banker G.A., Binder L.I. Immunocytochemical localization of tubulin and microtubule-associated protein 2 during the development of hippocampal neurons in culture. J. Neurosci. 6:1986;714-722.
19. Caceres A., Potrebic S., Kosik K.S. The effect of tau antisense oligonucleotides on neurite formation of cultured cerebellar macroneurons. J. Neurosci. 11:1991;1515-1523.
20. Campenot R.B., Draker D.D., Senger D.L. Evidence that protein kinase C activities involved in regulating neurite growth are localized to distal neurites. J. Neurochem. 63:1994;868-878.
21. Clark E.A., Leach K.L., Trojanowski J.Q., Lee V.M.-Y. Characterization and differential distribution of the three major human protein kinase C isozymes (PKC alpha, PKC beta, and PKC gamma) of the central nervous system in normal and Alzheimer's disease brains. Lab. Invest. 64:1991;35-44.
22. Cleveland D.W., Hwo S.Y., Kirschner M.W. Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. J. Mol. Biol. 116:1977;207-225.
23. Cole G., Dobkins K.R., Hansen L.A., Terry R.D., Saitoh T. Decreased levels of protein kinase C in Alzheimer's brain. Brain Res. 452:1988;165-174.
24. Couratier P., Lesort M., Condamines O., Mourton-Gilles C., Delacourte A., Hugon J. Phorbol ester enhances phosphorylated tau protein immunoreactivity in neuronal cultures. Neurosci. Lett. 203:1996;155-158.
25. Cressman C.M., Shea T.B. Hyperphosphorylation of tau and filopodial retraction following microinjection of protein kinase C catalytic subunits. J. Neurosci. Res. 42:1995;648-656.
26. Crowther R.A., Wischik C.M. Image reconstruction of the Alzheimer paired helical filament. EMBO J. 4:1985;3661-3665.
27. Deitch J.S., Banker G.A. An electron microscopic analysis of hippocampal neurons developing in culture: early stages in the emergence of polarity. J. Neurosci. 13:1993;4301-4315.
28. Dekker L.V., Parker P.J. Protein kinase C - a question of specificity. Trends Biochem. Sci. 19:1994;73-77.
29. Dostmann W.R.G., Taylor S.S., Genieser H.-G., Jastorff B., Doskeland S.O., Ogreld K. Probing the cyclic nucleotide binding sites of cAMP-dependent protein kinases I and II with analogs of adenosine 3′,5′-cyclic phosphorothioates. J. Biol. Chem. 265:1990;10484-10491.
30. Dreschel D.N., Hyman A.A., Cobb M.H., Kirschner M.W. Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau. Mol. Biol. Cell. 3:1992;1141-1154.
31. Drewes G., Lichtenberg-Kraag B., Doring F., Mandelkow E.M., Biernat J., Goris J., Doree M., Mandelkow E. Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state. EMBO J. 11:1992;2131-2138.
32. Drubin D., Kobayashi S., Kellogg D., Kirschner M. Regulation of microtubule protein levels during cellular morphogenesis in nerve growth factor-treated PC 12 cells. J. Cell Biol. 106:1988;1583-1591.
33. Drubin D., Kobayashi S., Kirschner M. Association of tau protein with microtubules in living cells. Ann. New York Acad. Sci. 466:1986;257-268.
34. Drubin D.G., Caput D., Kirschner M.W. Studies on the expression of the microtubule-associated protein, tau, during mouse brain development, with newly isolated complementary DNA probes. J. Cell Biol. 98:1984;1090-1097.
35. 3H]-PIP2 hydrolysis in Alzheimer's disease. Life Sci. 53:1993;439-444.
36. Ferreira A., Busciglio J., Caceres A. Microtubule formation and neurite growth in cerebellar macroneurons which develop in vitro: evidence for the involvement of the microtubule-associated proteins, MAP-1a, HMW-MAP 2 and tau. Dev. Brain Res. 49:1989;215-228.
37. Goedert M., Jakes R. Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. EMBO J. 9:1990;4225-4230.
38. Goedert M., Jakes R., Crowther R.A., Cohen P., Vanmechelen E., Vandermeeren M., Cras P. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. Biochem. J. 301:1994;871-877.
39. Goedert M., Jakes R., Crowther R.A., Six J., Lubke U., Vandermeeren M., Cras P., Trojanowski J.Q., Lee V.M. The abnormal phosphorylation of tau protein at ser-202 in Alzheimer disease recapitulates phosphorylation during development. Proc. Natl. Acad. Sci. U.S.A. 90:1993;5066-5070.
40. Goedert M., Jakes R., Vanmechelen E. Monoclonal antibody AT8 recognizes tau protein phosphorylated at both serine 202 and threonine 205. Neurosci. Lett. 189:1995;167-170.
41. Goedert M., Spillantini M.G., Cairns N.J., Crowther R.A. Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron. 8:1992;159-168.
42. Goedert M., Spillantini M.G., Potier M.C., Ulrich J., Crowther R.A. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J. 8:1989;393-399.
43. Gotoh Y., Nishida E., Yamashita T., Hoshi M., Kawashima M. Microtubule-associated-protein kinase (MAP) kinase activated by nerve growth factor and epidermal growth factor in PC12 cells. Identity with the mitogen activated MAP kinase of fibroblastic cells. Eur. J. Biochem. 193:1990;661-669.
44. Greenberg S.G., Davies P., Schein J.D., Binder L.I. Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. J. Biol. Chem. 267:1992;564-569.
45. Gustke N., Trinczek B., Biernat J., Mandelkow E.-M., Mandelkow E. Domains of tau protein and interactions with microtubules. Biochemistry. 33:1994;9511-9522.
46. Hasegawa M., Morishima-Kawashima M., Takio K., Suzuki M., Titani K., Ihara Y. Protein sequence and mass spectrometric analyses of tau in the Alzheimer's disease brain. J. Biol. Chem. 267:1992;17047-17054.
47. Herbert J.M., Augereau J.M., Gleye J., Maffrand J.P. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 172:1990;993-999.
48. Himmler A., Drechsel D., Kirschner M.W., David W., Martin J. Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains. Mol. Cell. Biol. 9:1989;1381-1388.
49. Hirokawa N., Shiomura Y., Okabe S. Tau proteins: the molecular structure and mode of binding on microtubules. J. Cell Biol. 107:1988;1449-1459.
50. 3H]phorbol 12,13-dibutyrate binding to protein kinase C in Alzheimer's disease. J. Neurochem. 56:1991;1121-1129.
51. Ihara Y. Massive somatodendritic sprouting of cortical neurons in Alzheimer's disease. Brain Res. 459:1988;138-144.
52. Jakes R., Novak M., Davison M., Wischik C.M. Identification of 3- and 4-repeat tau isoforms within the PHF in Alzheimer's disease. EMBO J. 10:1991;2725-2729.
53. Jope R.S., Song L., Li X., Powers R. Impaired phosphoinositide hydrolysis in Alzheimer's disease brain. Neurobiol. Aging. 15:1994;221-226.
54. Kanai Y., Hirokawa N. Sorting mechanisms of tau and MAP 2 in neurons: suppressed axonal transit of MAP 2 and locally regulated microtubule binding. Neuron. 14:1995;421-432.
55. Kanemaru K., Takio K., Miura R., Titani K., Ihara Y. Fetal-type phosphorylation of the tau in paired helical filaments. J. Neurochem. 58:1992;1667-1675.
56. Kondo J., Honda T., Mori H., Hamada Y., Miura R., Ogawara M., Ihara Y. The carboxyl third of tau is tightly bound to paired helical filaments. Neuron. 1:1988;827-834.
57. Kosik K.S. Alzheimer's disease: a cell biological perspective. Science. 256:1992;780-783.
58. Kosik K.S., Caceres A. Tau protein and the establishment of an axonal morphology. J. Cell Sci. S15:1991;69-74.
59. Kosik K.S., Finch E.A. MAP 2 and tau segregate into dendritic and axonal domains after the elaboration of morphologically distinct neurites: an immunocytochemical study of cultured rat cerebrum. J. Neurosci. 7:1987;3142-3153.
60. Kosik K.S., Orecchio L.D., Bakalis S., Neve R.L. Developmentally regulated expression of specific tau sequences. Neuron. 2:1989;1389-1397.
61. Kosik K.S., Orecchio L.D., Binder L., Trojanowski J.Q., Lee V.M., Lee G. Epitopes that span the tau molecule are shared with paired helical filaments. Neuron. 1:1988;817-825.
62. Ksiezak-Reding H., Yen S.-Y. Structural stability of paired helical filaments requires microtubule-binding domains of tau: a model for self-association. Neuron. 6:1991;717-728.
63. Lang E., Szendrei G.I., Lee V.M., Otvos L.J. Immunological and conformational characteristics of a phosphorylated immunodominant epitope on the paired helical filaments found in Alzheimer's disease. Biochem. Biophys. Res. Commun. 187:1992;783-790.
64. Lee G., Neve R.L., Kosik K.S. The microtubule binding domain of tau protein. Neuron. 2:1989;1615-1624.
65. Lee J.H., Goedert M., Hill W.D., Lee V.M.-Y., Trojanowski J.Q. Tau proteins are abnormally expressed in olfactory epithelium of Alzheimer patients and developmentally regulated in human fetal spinal cord. Exp. Neurol. 121:1993;93-105.
66. Lee V.M., Balin B.J., Otvos L. Jr., Trojanowski J.Q. A68: a major subunit of paired helical filaments and derivatized forms of normal tau. Science. 251:1991;675-678.
67. Lee V.M., Trojanowski J.Q. The disordered neuronal cytoskeleton in Alzheimer's disease. Curr. Opin. Neurobiol. 2:1992;653-656.
68. Lindwall G., Cole R.D. Phosphorylation affects the ability of tau protein to promote microtubule assembly. J. Biol. Chem. 259:1984;5301-5305.
69. Lloyd E.D., Wooten M.W. pp42/44 MAP kinase is a component of the neurogenic pathway utilized by nerve growth factor in PC12 cells. J. Neurochem. 59:1992;1099-1109.
70. Lu Q., Wood J.G. Functional studies of Alzheimer's disease tau protein. J. Neurosci. 13:1993;508-515.
71. Makowske M., Ballester R., Cayre Y., Rosen O.M. Immunochemical evidence that three protein kinase C isozymes increase in abundance during HL-60 differentiation induced by dimethyl sulfoxide and retinoic acid. J. Biol. Chem. 263:1988;3402-3410.
72. Mandell J.W., Banker G.A. The microtubule cytoskeleton and the development of neuronal polarity. Neurobiol. Aging. 16:1995;229-238.
73. Martin H., Lambert M.P., Barber K., Hinton S., Klein W.L. Alzheimer's-associated phospho-tau epitope in human neuroblastoma cell cultures: up-regulation by fibronectin and laminin. Neuroscience. 66:1995;769-779.
74. Masliah E., Cole G., Shimohama S., Hansen L., DeTeresa R., Terry R., Saitoh T. Differential involvement of protein kinase C isozymes in Alzheimer's disease. J. Neurosci. 10:1990;2113-2124.
75. Masliah E., Cole G.M., Hansen L.A., Mallory M., Albright T., Terry R.D., Saitoh T. Protein kinase C alteration is an early biochemical marker in Alzheimer's disease. J. Neurosci. 11:1991;2759-2767.
76. Masliah E., Mallory M., Hansen L., Alford M., Albright T., DeTeresa R., Terry R., Baudier J., Saitoh T. Patterns of aberrant sprouting in Alzheimer's disease. Neuron. 6:1991;729-739.
77. Mawal-Dewan M., Henley J., Van de Voorde A., Trojanowski J.Q., Lee V.M. The phosphorylation state of tau in the developing rat brain is regulated by phosphoprotein phosphatases. J. Biol. Chem. 269:1994;30981-30987.
78. McKee A.C., Kowall N.W., Kosik K.S. Microtubular reorganization and dendritic growth response in Alzheimer's disease. Ann. Neurol. 26:1989;652-659.
79. Miller B.L., Moats R.A., Shonk T., Ernst T., Woolley S., Ross B.D. Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. Radiology. 187:1993;433-437.
80. Morishima-Kawashima M., Hasegawa M., Takio K., Suzuki M., Yoshida H., Titani K., Ihara Y. Proline-directed and non-proline-directed phosphorylation of PHF-tau. J. Biol. Chem. 270:1995;823-829.
81. Morishima-Kawashima M., Hasegawa M., Takio K., Suzuki M., Yoshida H., Watanabe A., Titani K., Ihara Y. Hyperphosphorylation of tau in PHF. Neurobiol. Aging. 16:1995;365-380.
82. Neve R.L., Harris P., Kosik K.S., Kurnit D.M., Donlon T.A. Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for L tau and microtubule-associated protein 2. Mol. Brain Res. 1:1986;271-280.
83. Nishizuka Y. Studies and prospectives of the protein kinase C family for cellular regulation. Cancer. 63:1989;1892-1903.
84. Oda T., Shearman M.S., Nishizuka Y. Synaptosomal protein kinase C subspecies: B. Down-regulation promoted by phorbol ester and its effect on evoked norepinephrine release. J. Neurosci. 10:1991;2113-2124.
85. Ohtsubo K., Izumiyama N., Kuzuhara S., Mori H., Shimada H. Curly fibers are tau-positive strands in the pre- and post-synaptic neurites, consisting of paired helical filaments: observations by the freeze-etch and replica method. Acta Neuropathol. 81:1990;111-115.
86. Papasozomenos S.C. Tau protein immunoreactivity in dementia of the Alzheimer type: I. Morphology, evolution, distribution, and pathogenic implications. Lab. Invest. 60:1989;123-137.
87. Papasozomenos S.C. Tau protein immunoreactivity in dementia of the Alzheimer type: II. Electron microscopy and pathogenic implications. Lab. Invest. 60:1989;375-389.
88. Pears C.J., Parker P.J. Domain interactions in protein kinase C. J. Cell Sci. 100:1991;683-686.
89. Pettegrew J.W. Molecular insights into Alzheimer's disease. Ann. New York Acad. Sci. 568:1989;5-28.
90. Pope W., Enam S.A., Bawa N., Miller B.E., Ghanbari H.A., Klein W.L. Phosphorylated tau epitope of Alzheimer's disease is coupled to axon development in the avian central nervous system. Exp. Neurol. 120:1993;106-113.
91. Probst A., Baler V., Bron B., Ulrich J. Neuritic plaques in senile dementia of Alzheimer's type: a Golgi analysis in the hippocampal region. Brain Res. 268:1983;249-254.
92. Riederer B.M., Binder L.I. Differential distribution of tau proteins in developing cat cerebellum. Brain Res. Bull. 33:1994;155-161.
93. 2+-sensitive, phospholipid-dependent protein kinase activity in phorbol ester-treated 3T3 cells. Biochem. Biophys. Res. Commun. 120:1984;1053-1059.
94. Roisin M.P., Barbin G. Differential expression of PKC isoforms in hippocampal neuronal cultures: modifications after basic FGF treatment. Neurochem. Int. 30:1997;261-270.
95. Saitoh T., Masliah E., Jin L.-W., Cole G.M., Wieloch T., Shapiro I.P. Protein kinases and phosphorylation in neurologic disorders and cell death. Lab. Invest. 64:1991;596-616.
96. Schmidt M.L., Murray J.M., Trojanowski J.Q. Continuity of neuropil threads with tangle-bearing and tangle-free neurons in Alzheimer's disease cortex. Mol. Chem. Neuropathol. 18:1993;299-311.
97. Segal M. Rat hippocampal neurons in culture: responses to electrical and chemical stimuli. J. Neurophysiol. 50:1983;1249-1264.
98. Seubert P., Mawal-Dewan M., Barbour R., Jakes R., Goedert M., Johnson V.W., Litersky J.M., Schenk D., Lieberburg I., Trojanowski J.Q., Lee V.M.-Y. Detection of phosphorylated ser262 in fetal tau, adult tau, and paired helical filament tau. J. Biol. Chem. 270:1995;18917-18922.
99. Shea T.B., Spencer M.J., Beerman M.L., Cressman C.M., Nixon R.A. Calcium influx into human neuroblastoma cells induces ALZ-50 immunoreactivity: involvement of calpain-mediated hydrolysis of protein kinase C. J. Neurochem. 66:1996;1539-1549.
100. Sheibel A.B., Tomiyasu U. Dendritic sprouting in Alzheimer's presenile dementia. Exp. Neurol. 60:1978;1-8.
101. Shimohama S., Fujimoto S., Taniguchi T., Kimura J. Phosphatidylinositol-specific phospholipase C activity in the postmortem human brain: no alteration in Alzheimer's disease. Brain Res. 579:1992;347-349.
102. Shimohama S., Narita M., Matsushima H., Kimura J., Kameyama M., Hagiwara M., Hidaka H., Taniguchi T. Assessment of protein kinase C isozymes by two-site enzyme immunoassay in human brains and changes in Alzheimer's disease. Neurology. 43:1993;1407-1413.
103. Shimohama S., Ninomiya H., Saitoh T., Terry R.D., Fukunaga R., Taniguchi T., Fujiwara M., Kimura J., Kameyama M. Changes in signal transduction in Alzheimer's disease. J. Neural Trans. 30:1990;69-78.
104. Shin R.-W., Iwaki T., Kitamoto T., Sato Y., Tateishi J. Massive accumulation of modified tau and severe depletion of normal tau characterize the cerebral cortex and white matter of Alzheimer's disease. Am. J. Pathol. 140:1992;937-945.
105. Stokes C.E., Hawthorne J.N. Reduced phosphoinositide concentrations in anterior temporal cortex of Alzheimer-diseased brain. J. Neurochem. 48:1987;1018-1021.
106. Szendrei G.I., Lee V.M., Otvos L. Jr. Recognition of the minimal epitope of monoclonal antibody Tau 1 depends upon the presence of a phosphate group but not its location. J. Neurosci. Res. 34:1993;243-249.
107. 2+/calmodulin-dependent protein kinase II. J. Biol. Chem. 265:1990;4315-4320.
108. Tourtellotte W.G., Van Hoesen G.W. The axonal origin of a subpopulation of dystrophic neurites in Alzheimer's disease. Neurosci. Lett. 129:1991;11-16.
109. Trojanowski J., Schmidt M., Shin R.-W., Bramblett G., Rao D., Lee V. Altered tau and neurofilament proteins in neurodegenerative diseases: diagnostic implications for Alzheimer's disease and Lewy body dementias. Brain Pathol. 3:1993;45-54.
110. Trojanowski J.Q., Schuck T., Schmidt M.L., Lee V.M.-Y. Distribution of tau proteins in the normal human central and peripheral nervous system. J. Histochem. Cytochem. 37:1989;209-215.
111. VanRenterghem B., Browning M.D., Maller J.L. Regulation of mitogen-activated protein kinase activation by protein kinase A and C in a cell-free system. J. Biol. Chem. 269:1996;24666-24672.
112. Vila J., Weber M.J. Mitogen-stimulated tyrosine phosphorylation of a 42-kDa cellular protein: evidence for a protein kinase-C requirement. J. Cell. Physiol. 135:1988;285-292.
113. Wang H., Pisano M.R., Friedman E. Attenuated protein kinase C activity and translocation in Alzheimer's disease brain. Neurobiol. Aging. 15:1994;293-298.
114. Wang Y., Loomis P.A., Zinkowski R.P., Binder L.I. A novel tau transcript in cultured human neuroblastoma cells expressing nuclear tau. J. Cell Biol. 121:1993;257-267.
115. Watanabe A., Hasegawa M., Suzuki M., Takio K., Morishima-Kawashima M., Titani K., Arai T., Kosik K., Ihara Y. In vivo phosphorylation sites in fetal and adult rat tau. J. Biol. Chem. 268:1993;25712-25717.
116. Wen G.Y., Wisniewski H.M. High resolution of paired helical filaments in Alzheimer's disease. J. Electron Microsc. 5:1987;347-355.
117. Wille H., Drewes G., Biernat J., Mandelkow E.M., Mandelkow E. Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro. J. Cell Biol. 118:1992;573-584.
118. Wolozin B., Scicutella A., Davies P. Reexpression of a developmentally regulated antigen in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 85:1988;6202-6206.
119. Yoshida H., Ihara Y. Tau in paired helical filaments is functionally distinct from fetal tau: assembly incompetence of paired helical filament-tau. J. Neurochem. 61:1993;1183-1186.
120. 3H]inositol 1,4,5-triphosphate binding in Alzheimer's disease. Neurosci. Lett. 94:1988;198-202.